However, compounded drugs do not go through the same quality, effectiveness, and safety checks as drugs approved by the Food and Drug Administration (FDA)
For anyone with hypertension or cardiovascular risk, semaglutide is the safer choice by a wide margin
Current guidelines do not recommend routine amylase and lipase monitoring for all semaglutide users
Some claimants may receive more or less based on specific factors of their case
While Ozempic and Wegovy contain semaglutide, a GLP-1 receptor agonist, Zepbound offers a dual GLP-1/GIP approach, and Mounjaro combines effects on both GIP and GLP-1 receptors for enhanced metabolic benefits
Combining a hepatically-challenged metabolism of bupropion with the general metabolic demands of tirzepatide therapy requires careful monitoring of liver enzymes and possibly reduced dosing of bupropion